drugset / Trial / NCT01805934

Quadruple Therapy Versus Dual Therapy as Rescue Regimens for Helicobacter Pylori Infection

NCT01805934

Phase 2 Completed 114 enrolled Shanghai Jiao Tong University School of Medicine
RandomizedParallel-groupDouble-blindTreatment

Summary

The eradication rates of first-line treatment for Helicobacter pylori(Hp) infection are not satisfactory. The study aims to compare the efficacy and safety between quadruple therapy with furazolidone and dual therapy with high doses of amoxicillin as rescue regimens for Hp.

Timeline

Start
2012-05
Primary completion
2012-12
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 1000 mg
Comparator Bismuth Potassium Citrate Unknown 220 mg
Comparator Furazolidone Small molecule 100 mg
Comparator Levofloxacin Small molecule 200 mg
Comparator Rabeprazole Small molecule 10 mg
Comparator Rabeprazole Small molecule 20 mg

Indications

No indication recorded.